Conference
Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study
Authors
Wechsler M; Nair P; Terrier B; Walz B; Bourdin A; Jayne D; Jackson D; Roufosse F; Sjö LB; Fan Y
Volume
153
Publisher
Elsevier
Publication Date
February 1, 2024
DOI
10.1016/j.jaci.2023.11.868
Conference proceedings
The Journal of Allergy and Clinical Immunology
Issue
2
ISSN
0091-6749
